PURA VIDA INVESTMENTS, LLC - Q4 2016 holdings

$273 Million is the total value of PURA VIDA INVESTMENTS, LLC's 70 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 275.0% .

 Value Shares↓ Weighting
SPY NewSPDR S&P 500 ETF TRput$19,559,00087,500
+100.0%
7.17%
XLV NewSELECT SECTOR SPDR TRput$11,892,000172,500
+100.0%
4.36%
UNH NewUNITEDHEALTH GROUP INC$10,003,00062,500
+100.0%
3.67%
ATHN BuyATHENAHEALTH INC$9,991,000
+44.0%
95,000
+72.7%
3.66%
+73.8%
ABBV NewABBVIE INC$9,416,000150,375
+100.0%
3.45%
EVHC NewENVISION HEALTHCARE CORP$8,965,000141,644
+100.0%
3.29%
HOLX NewHOLOGIC INC$8,603,000214,425
+100.0%
3.15%
BSX BuyBOSTON SCIENTIFIC CORP$8,219,000
+72.7%
380,000
+90.0%
3.01%
+108.4%
BCR NewBARD C R INC$8,200,00036,500
+100.0%
3.01%
IWM NewISHARES TRput$8,091,00060,000
+100.0%
2.97%
IEV NewISHARES TReurope etf$7,219,000186,000
+100.0%
2.65%
NUVA NewNUVASIVE INC$7,073,000105,000
+100.0%
2.59%
HUM NewHUMANA INC$6,835,00033,500
+100.0%
2.51%
PEN BuyPENUMBRA INC$6,061,000
+59.5%
95,000
+90.0%
2.22%
+92.5%
SYK NewSTRYKER CORPput$5,991,00050,000
+100.0%
2.20%
BIO NewBIO RAD LABS INCcl a$5,560,00030,500
+100.0%
2.04%
GMED NewGLOBUS MED INCcl a$4,962,000200,000
+100.0%
1.82%
CYNO BuyCYNOSURE INCcl a$4,560,000
+49.2%
100,000
+66.7%
1.67%
+80.2%
ILMN NewILLUMINA INC$4,481,00035,000
+100.0%
1.64%
INGN NewINOGEN INCput$4,366,00065,000
+100.0%
1.60%
BSX NewBOSTON SCIENTIFIC CORPcall$4,326,000200,000
+100.0%
1.59%
TMO NewTHERMO FISHER SCIENTIFIC INCput$4,233,00030,000
+100.0%
1.55%
GKOS NewGLAUKOS CORP$3,770,000109,903
+100.0%
1.38%
GWPH BuyGW PHARMACEUTICALS PLCads$3,604,000
-2.5%
32,250
+15.8%
1.32%
+17.6%
NSTG BuyNANOSTRING TECHNOLOGIES INC$3,597,000
+85.6%
161,311
+66.3%
1.32%
+123.9%
QSII NewQUALITY SYS INC$3,506,000266,617
+100.0%
1.28%
CFMS NewCONFORMIS INC$3,396,000419,235
+100.0%
1.24%
ICUI NewICU MED INC$3,315,00022,500
+100.0%
1.22%
ELGX NewENDOLOGIX INC$2,860,000500,000
+100.0%
1.05%
LPNT NewLIFEPOINT HEALTH INCput$2,840,00050,000
+100.0%
1.04%
XRAY NewDENTSPLY SIRONA INC$2,742,00047,500
+100.0%
1.00%
EWA NewISHAREScall$2,024,000100,000
+100.0%
0.74%
QSII NewQUALITY SYS INCcall$1,911,000145,300
+100.0%
0.70%
BuyNEURODERM LTD$1,780,000
+139.6%
80,183
+99.5%
0.65%
+188.9%
ANIP NewANI PHARMACEUTICALS INC$1,591,00026,250
+100.0%
0.58%
SUPN NewSUPERNUS PHARMACEUTICALS INC$1,389,00055,000
+100.0%
0.51%
ARRY BuyARRAY BIOPHARMA INC$1,383,000
+581.3%
157,360
+424.5%
0.51%
+717.7%
IMMU BuyIMMUNOMEDICS INC$1,235,000
+18.9%
336,500
+5.3%
0.45%
+43.4%
AGRX BuyAGILE THERAPEUTICS INC$938,000
+439.1%
164,501
+560.6%
0.34%
+549.1%
ALDX BuyALDEYRA THERAPEUTICS INC$669,000
-25.0%
125,000
+9.6%
0.24%
-9.6%
XENT NewINTERSECT ENT INCcall$645,0003,000
+100.0%
0.24%
OCRX BuyOCERA THERAPEUTICS INC$544,000
-17.2%
258,893
+4.0%
0.20%
-0.5%
BVX NewBOVIE MEDICAL CORP$442,000123,000
+100.0%
0.16%
AXGN NewAXOGEN INC$222,00024,700
+100.0%
0.08%
ELGX NewENDOLOGIX INCput$26,0004,600
+100.0%
0.01%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ICU MED INC26Q2 20234.2%
NANOSTRING TECHNOLOGIES INC26Q2 20233.3%
VIEWRAY INC25Q2 20233.2%
LIVANOVA PLC23Q3 20233.8%
ALEXION PHARMACEUTICALS INC23Q1 20214.3%
INSPIRE MED SYS INC22Q3 20233.7%
BOSTON SCIENTIFIC CORP22Q3 20224.8%
INVACARE CORP22Q3 20212.8%
ESTABLISHMENT LABS HLDGS INC21Q3 20235.0%
INTERSECT ENT INC21Q2 20212.6%

View PURA VIDA INVESTMENTS, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
PURA VIDA INVESTMENTS, LLC Q4 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Stryve Foods Holdings, LLCApril 19, 20231,470,6495.6%
ICAD INCMarch 15, 20231,277,2145.0%
ESTABLISHMENT LABS HOLDINGS INC.February 14, 20231,002,7674.1%
Pulmonx CorpFebruary 14, 20231,216,2583.2%
Quotient LtdSold outFebruary 14, 202300.0%
Universe Pharmaceuticals INCSold outFebruary 14, 202300.0%
MedMen Enterprises, Inc.April 29, 2022139,755,07221.4%
INVACARE CORPSold outFebruary 14, 202200.0%
MedAvail Holdings, Inc.February 14, 2022714,1202.2%
TELA Bio, Inc.February 14, 2022564,1203.9%

View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2024-02-13

View PURA VIDA INVESTMENTS, LLC's complete filings history.

Compare quarters

Export PURA VIDA INVESTMENTS, LLC's holdings